Changes in calcium homoeostasis in patients undergoing liver transplantation: Effects of a single infusion of pamidronate administered pre-operatively

Clinical Science

Volumn 97, Issue 2, 1999, Pages 157-163

  Bishop, N J ^a   Ninkovic, M ^a   Alexander, G J M ^a   Holmes, S D ^b   Milligan, T ^c   Price, C ^c   Compston, Juliet E ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b New Frontiers Science Park   (United Kingdom)

^c ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

Bisphosphonates; Liver transplantation; Parathyroid hormone

Indexed keywords

ACID PHOSPHATASE; ALKALINE PHOSPHATASE; CALCIUM; PAMIDRONIC ACID; PARATHYROID HORMONE; SERUM ALBUMIN;

ADULT; AGED; ARTICLE; BONE ATROPHY; BONE METABOLISM; BONE TURNOVER; CALCIUM BLOOD LEVEL; CALCIUM HOMEOSTASIS; CHRONIC LIVER DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FRACTURE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LIVER TRANSPLANTATION; OSSIFICATION; OSTEOLYSIS; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS; BONE RESORPTION; CALCIUM; DIPHOSPHONATES; FEMALE; HOMEOSTASIS; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; OSTEOGENESIS; PARATHYROID HORMONE; PHOSPHATES; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; SINGLE-BLIND METHOD;

EID: 0032840667     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS19990086     Document Type: Article

References (26)

1. 1 Epstein, S., Shane, E. and Bilezikian, J. P. (1995) Organ transplantation and osteoporosis. Curr. Opin. Rheumatol. 7, 255-261
2. 2 Hill, S. A., Kelly, D. A. and John, P. R. (1995) Bone fractures in children undergoing orthotopic liver transplantation. Pediatr. Radiol. 25 (Suppl. 1), S112-S117
3. 3 Peris, P., Navasa, M., Guanabens, N. et al. (1993) Sacral stress fracture after liver transplantation. Br. J. Rheumatol. 32, 702-704
4. 4 Sambrook, P. N., Kelly, P. J., Keogh, A. M. et al. (1994) Bone loss after heart transplantation: a prospective study. J. Heart Lung Transplant. 13, 116-120
5. 5 Abdelhadi, M., Eriksson, S. A., Ljusk Eriksson, S., Ericzon, B. G. and Nordenstrom, J. (1995) Bone mineral status in end-stage liver disease and the effect of liver transplantation. Scand. J. Gastroenterol. 30, 1210-1215
6. 6 Arnold, J. C., Hauser, D., Ziegler, R. et al. (1992) Bone disease after liver transplantation. Transplant. Proc. 24, 2709-2710
7. 7 Compston, J. E. (1986) Hepatic osteodystrophy: vitamin D metabolism in patients with liver disease [Review]. Gut 27, 1073-1090
8. 8 Compston, J. E., Greer, S., Skingle, S. J. et al. (1996) Early increase in plasma parathyroid hormone levels following liver transplantation. J. Hepatol. 25, 715-718
9. 9 Black, D. M., Cummings, S. R., Karpf, D. B. et al. (1996) Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Lancet 348, 1535-1541
10. 10 Rodan, G. A. and Balena, R. (1993) Bisphosphonates in the treatment of metabolic bone diseases. Ann. Med. 25, 373-378
11. 11 Tal, A. and Graves, L. (1996) Intravenous pamidronate for hypercalcemia of primary hyperparathyroidism. South. Med. J. 89, 637-640
12. 12 Wimalawansa, S. J. and Gunasekera, R. D. (1993) Pamidronate is effective for Paget's disease of bone refractory to conventional therapy. Calcif. Tissue Int. 53, 237-241
13. 13 Chamberlain, P., Compston, J., Cox, T. M. et al. (1995) Generation and characterization of monoclonal antibodies to human type-5 tartrate-resistant acid phosphatase: development of a specific immunoassay of the isoenzyme in serum. Clin. Chem. 41, 1495-1499
14. 14 Body, J. J., Dumon, J. C., Piccart, M. and Ford, J. (1995) Intravenous pamidronate in patients with tumor-induced osteolysis: a biochemical dose-response study. J. Bone Miner. Res. 10, 1191-1196
15. 15 McCloskey, E. V., Yates, A. J. P., Beneton, M. N. C., Galloway, J., Harris, S. and Kanis, J. A. (1987) Comparative effects of intravenous diphosphonates on calcium and skeletal metabolism in man. Bone 8, S35-S41
16. 16 Roux, C., Ravaud, P., Cohen-Solal, M. et al. (1994) Biologic, histologic and densitometric effects of oral risedronate on bone in patients with multiple myeloma. Bone 15, 41-49
17. 17 Flach, R., Speidel, N., Flohe, S. et al. (1998) Analysis of intragraft cytokine expression during early reperfusion after liver transplantation using semi-quantitative RT-PCR. Cytokine 10, 445-451
18. 18 Boros, P., Suehiro, T., Curtiss, S. et al. (1997) Differential contribution of graft and recipient to perioperative TNF-alpha, IL-1 beta, IL-6 and IL-8 levels and correlation with early graft function in clinical liver transplantation. Clin. Transplant. 11, 588-592
19. 19 Simpson, K. J., Lukacs, W., Colletti, L., Streiter, R. M. and Kunkel, S. L. (1997) Cytokines and the liver. J. Hepatol. 27, 1120-1132
20. 20 Lorenzo, J. A., Sousa, S. L., Alander, C., Raisz, L. G. and Dinarello, C. A. (1987) Comparison of the bone-resorbing activity in the supernatants from phytohemagglutinin-stimulated peripheral blood mononuclear cells with that of cytokines through the use of an antiserum to interleukin 1. Endocrinology (Baltimore) 121, 1164-1170
21. 21 Akatsu, T., Takahashi, N., Udagawa, N. et al. (1991) Role of prostaglandins in interleukin-1-induced bone resorption in mice in vitro. J. Bone Miner. Res. 6, 183-190
22. 22 Black, K., Garrett, I. R. and Mundy, G. R. (1991) Chinese hamster ovarian cells transfected with the murine interleukin-6 gene cause hypercalcemia as well as cachexia, leukocytosis and thrombocytosis in tumor-bearing nude mice. Endocrinology (Baltimore) 128, 2657-2659
23. 23 Johnson, R. A., Boyce, B. F., Mundy, G. R. and Roodman, G. D. (1989) Tumors producing human tumor necrosis factor induce hypercalcemia and osteoclastic bone resorption in nude mice. Endocrinology (Baltimore) 124, 1424-1427
24. 24 Movsowitz, C., Epstein, S., Fallon, M. et al. (1988) Cyclosporin A in vivo produces severe osteopenia in the rat: effect of dose and duration of administration. Endocrinologv (Baltimore) 123, 2571-2577
25. 25 Eastell, R. and Blumsohn, A. (1996) Biochemical markers of bone turnover in osteoporosis. In Osteoporosis, New Perspectives on Causes, Prevention and Treatment (Compston, J. E., ed.), Royal College of Physicians, London
26. 26 Vedi, S., Greer, S., Skingle, S. J. et al. (1999) Mechanism of bone loss after liver transplantation: a histomorphometric study. J. Bone Miner. Res. 14, 281-287